KAVEH, S.; EBRAHIMI, P.; REZAPOUR, A.; MOZAFARI, M.; SAYEHMIRI, K. Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer. International Pharmacy Acta, [S. l.], v. 1, n. 1, p. 19–20, 2018. DOI: 10.22037/ipa.v1i1.20015. Disponível em: https://journals.sbmu.ac.ir/acta/article/view/20015. Acesso em: 7 may. 2024.